Business
Rebuilding Trust: How Glucotrack Is Establishing A New Standard In Diabetes Management
By JE Insights, Benzinga DETROIT, MICHIGAN - June 10, 2025 (NEWMEDIAWIRE) - While the genesis of typical modern medical technologies focuses on a specific
About this update from Glucotrack, Inc.
[{"type":"text","content":"By JE Insights, Benzinga \nDETROIT, MICHIGAN - June 10, 2025 (NEWMEDIAWIRE) - While the genesis of typical modern medical technologies focuses on a specific design element or research protocol, for Glucotrack Inc. (NASDAQ: GCTK), the basis of innovation begins at the human level. It's the reason why earlier this year, the medical device firm - which specializes in the development of a fully implantable continuous blood glucose monitoring (CBGM) system - formed a Patient Advisory Board (PAB).\n This group of individuals, who live with type 1 diabetes, offered day-to-day insights into the challenges, frustrations and limitations of current diabetes management tools. Unlike traditional focus groups, which often align with marketing interests, Glucotrack's PAB was structured specifically for ongoing dialogue between the company's development team and the patients whose lives have been directly shaped by glucose monitoring technologies.\nThroughout the board's inaugural meeting, Glucotrack encouraged patients to speak candidly about their experiences with traditional continuous glucose monitoring (CGM) systems. Over the course of the dialogue, the company reports that a clear motif emerged: diabetes patients carried a deep distrust toward existing glucose monitoring solutions - a distrust that has both emotional and clinical consequences.\nThe Trust Deficit: Addressing Core Concerns Among Diabetes Patients\nThroughout the first PAB meeting, type 1 diabetes patients - while acknowledging the broader advancements in medical technology - still had deep issues regarding the reliability of the data that traditional CGMs provide. Among the key issues raised were the following:\n Inaccuracy: Common CGM systems sometimes produced less accurate (or delayed) readings, especially following an exercise session, during illnesses or when taking medication (including over-the-counter drugs like Tylenol).\n\n Compression lows: False alarms have been triggered by simple actions such as sleeping on the sensor.\n\n Allergic reactions: While many people tolerate the adhesives with no complaints, the reality can be far different for some.\n\n Emotional toll: Some patients described hiding their diabetes from friends, partially in an effort to avoid looking sick.\n\n \n To respond to this opportunity gap, Glucotrack has developed its CBGM. Rather than an ...